Head & Neck Cancers
Efficacy Maintained, QoL Improved With Radiation Dose Reductions in Oropharyngeal Cancer
Read More >>
View Free CME from PER >>
Pembrolizumab Benefit in SCCHN Confirmed in Expansion Study
Study Adds Pembrolizumab to Paradigm for Certain Head and Neck Cancers
Olanzapine Shown to Control CINV in Patients With Esophageal, Head and Neck Cancer
Bill Takes Aim at High Copays for Self-Injectable and Oral Cancer Drugs
Preventive Neck Lymph Node Surgery Should Become Standard of Care in Early Oral Cancer
View More >>
See the latest in research and cutting edge developments from our partner institutions
- A Network of Your Peers
View more >>
Dr. Villaflor on RAVD of Radiotherapy With Induction Chemotherapy in HNSCC
Dr. Seiwert on Pembrolizumab in Head and Neck Cancer
Investigational Therapies for Thyroid Cancer
Frontline Treatment Selection in RAI-Refractory DTC
Importance of Multidisciplinary Thyroid Cancer Care
In this discussion, panelists explore the importance of multidisciplinary care for patients with locally advanced or metastatic thyroid cancer.
Treatment Selection in Advanced MTC
In this segment, panelists discuss the frontline treatment selection for patients with advanced medullary thyroid cancer who are not candidates for surgery.
Medullary Thyroid Cancer: Advances and Challenges
Moderated by Ezra Cohen, MD, this panel discussion includes expert perspectives from Eric J. Sherman, MD, Steven I. Sherman, MD, R. Michael Tuttle, MD, and Lori J. Wirth, MD.
8th Annual Multidisciplinary Symposium on Head and Neck Cancer: Medical Crossfire
CME activity worth 2.0 CME credits led by James Tate Thigpen, MD.
Most Popular Right Now
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2015
Intellisphere, LLC. All Rights Reserved.